EXPERIMENT WITH MEDICINES: Karl-Henning Kalland (left), Yi Qu and Xisong Ke have experimented with hundreds of substances on cancer. Photo: Kim E. Andreassen via: UiB
Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.
Cancer researchers at the University of Bergen (UiB) have in the recent years experienced with hundreds of known drugs, to see how they influence cancer cells.
Recently they found that a substance in medicine against parasites like Giardia and Tapeworms, acts like tailored medicine against prostate- and colon cancer.
“We discovered that this specific substance is blocking the signalling pathway in the cancer cells, and make them stop growing. It is not often that researchers discover a substance that targets specific molecules as precisely as this one, ” says Professor Karl-Henning Kalland at the Department of Clinical Science, at UiB. He is the leader of the Kalland´s Research Group.
The study is published in Nature Chemical Biology.
Hyperactive cells
The researchers Yi Qu and Xisong Ke at Kalland team saw that the cells in prostate- and colon cancer contain high amounts of activated Beta-catenin. Activation of this protein makes the cells go amok and divides at high tempo. In addition, Beta-catenin makes the cancer cells more resistant and more able for survival.
In the study, Qu and Ke discovered that it was the substance NTZ (nitazoxanide), a well known and approved anti-parasite drug, that decompose the activated Beta-catenin.
“We are the first researchers who have mapped the complex molecular mechanisms involved in this process,” Kalland says.
Recycling old medicines
Experiments with well-known drugs show that a medicine may have different and unknown targets in the cells.
“The advantage of testing already approved drugs, is that we know they work in the human body and have no serious side effects, which means that a future treatment may happen quicker,” Kalland explains.
Strengthen the immune system
NTZ attacks cancer celles by hindering the activated Beta-catenin. It appears that this hindering also stimulates central parts of the immune system, that attacks cancer cells.
“At the moment, we are working on how to strengthen our on going immune therapy against prostate cancer by using the mechanisms we discovered of the NTZ,” Kalland says.
Kalland and his research-team is in the first phase in a clinical trial using immune therapy against prostate cancer.
Learn more: Tapeworm drug fights Prostate Cancer
The Latest on: Immune therapy
[google_news title=”” keyword=”immune therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Can lymph nodes boost the success of cancer immunotherapy?on March 21, 2023 at 3:03 pm
Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells. But new findings from a clinical trial show that immunotherapy can activate ...
- Non-canonical proteins as candidate targets for cancer immunotherapyon March 21, 2023 at 1:21 pm
Recently published in Clinical Cancer Research, a study led by Alena Gros, Principal Investigator of the Vall d'Hebron Institute of Oncology's Tumor Immunology and Immunotherapy Group, tested more ...
- Leaving lymph nodes intact until after immunotherapy could boost efficacy against solid tumorson March 20, 2023 at 11:27 pm
Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells.
- Immunotherapy Market Size and Forecast till 2028on March 20, 2023 at 9:20 pm
The "Immunotherapy Market" Study Describes how the technology industry is evolving and how major and emerging players ...
- Cancer Immunotherapy Market Share and Forecast till 2028on March 20, 2023 at 8:01 pm
The "Cancer Immunotherapy Market" study describes how the technology industry is evolving and how major and emerging players in the industry are responding to long term opportunities and short-term ...
- BioNTech Puts Up $200M to Partner With OncoC4 in Cancer Immunotherapyon March 20, 2023 at 4:48 pm
BioNTech is expanding its cancer immunotherapy scope by partnering with OncoC4 on clinical testing of its lead drug. The antibody was designed to offer a safety edge over other CTLA-4-blocking drugs ...
- Cancer Breakthrough: “Hard To Lose” Mutations in Tumors May Predict Response to Immunotherapyon March 20, 2023 at 11:39 am
Cancer specialists have attempted to utilize the number of mutations in a tumor, known as the tumor mutation burden (TMB), to forecast a patient's response to immunotherapy, with varying degrees of ...
- Flush with cash, BioNTech buys into an immunotherapy to rival Yervoyon March 20, 2023 at 9:52 am
The COVID-19 vaccine maker is paying $200 million to secure rights to an experimental CTLA-4 inhibitor that privately held OncoC4 designed to have fewer side effects.
- Synthetic protein tweak could lead to universal cancer immunotherapyon March 19, 2023 at 7:35 pm
Scientists at ETH Zurich have made a breakthrough towards designing an off-the-shelf treatment for immunotherapy against cancer. A synthetic protein tweak can allow immune cells from any donor to be ...
- New immunotherapy strategies in targeting complexity in the tumor microenvironmenton March 19, 2023 at 3:51 am
A symposium aiming to provide a better understanding of the tumor microenvironment, immune tolerogenic niches at cancer initiation, and novel immunotherapeutic strategies in head and neck cancer ...
via Google News and Bing News
Go deeper with Bing News on:
Immune system
- Immune Signals in the Brain Could Lead to Addiction Vulnerability
Carmon and colleagues focused on the relationship between the brain’s choline transporter—a protein in the cell membrane involved in attentional control—and cytokines—proteins that stimulate or slow ...
- Insights into causes of rare genetic immune disorders
The cellular glitches underlying a rare genetic disorder called activated PI3K Delta syndrome 2 (APDS2) have been identified. The disorder is caused by genetic variations that disrupt immune cell ...
- New evidence: Immune system cells in the gut linked to stress-induced depression
In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may ...
- Immune system cells in the gut linked to stress-induced depression
In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may ...
- Birds may take migration pit stops to boost their immune systems
Researchers once thought that when birds took breaks along long migration routes, they were stopping to build up their fat reserves.
Go deeper with Google Headlines on:
Immune system
[google_news title=”” keyword=”immune system” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Immune therapy
- Can lymph nodes boost the success of cancer immunotherapy?
Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells. But new findings from a clinical trial show that immunotherapy can activate ...
- Non-canonical proteins as candidate targets for cancer immunotherapy
Recently published in Clinical Cancer Research, a study led by Alena Gros, Principal Investigator of the Vall d'Hebron Institute of Oncology's Tumor Immunology and Immunotherapy Group, tested more ...
- Leaving lymph nodes intact until after immunotherapy could boost efficacy against solid tumors
Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells.
- Immunotherapy Market Size and Forecast till 2028
The "Immunotherapy Market" Study Describes how the technology industry is evolving and how major and emerging players ...
- Cancer Immunotherapy Market Share and Forecast till 2028
The "Cancer Immunotherapy Market" study describes how the technology industry is evolving and how major and emerging players in the industry are responding to long term opportunities and short-term ...
Go deeper with Google Headlines on:
Immune therapy
[google_news title=”” keyword=”immune therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
